DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,038,000 | +25072.6% | 375 | -75.6% | 0.03% | -73.8% |
| Q2 2023 | $369,600 | +39.0% | 1,540 | +46.0% | 0.12% | +43.5% |
| Q1 2023 | $265,902 | +48.4% | 1,055 | +56.3% | 0.08% | +44.1% |
| Q4 2022 | $179,159 | -1.6% | 675 | -4.3% | 0.06% | +5.4% |
| Q3 2022 | $182,000 | +4.6% | 705 | +2.9% | 0.06% | +19.1% |
| Q2 2022 | $174,000 | +30.8% | 685 | +50.5% | 0.05% | +161.1% |
| Q1 2022 | $133,000 | -30.4% | 455 | -21.6% | 0.02% | -25.0% |
| Q4 2021 | $191,000 | -5.0% | 580 | -12.1% | 0.02% | -11.1% |
| Q3 2021 | $201,000 | -60.4% | 660 | -65.1% | 0.03% | -60.3% |
| Q2 2021 | $507,000 | +9.3% | 1,890 | -8.3% | 0.07% | +7.9% |
| Q1 2021 | $464,000 | -75.2% | 2,060 | -75.6% | 0.06% | -73.8% |
| Q4 2020 | $1,874,000 | +618.0% | 8,438 | +597.4% | 0.24% | +515.4% |
| Q3 2020 | $261,000 | +13.5% | 1,210 | -6.9% | 0.04% | +2.6% |
| Q2 2020 | $230,000 | -34.3% | 1,300 | -43.0% | 0.04% | -26.9% |
| Q4 2019 | $350,000 | +288.9% | 2,280 | +267.7% | 0.05% | +246.7% |
| Q3 2019 | $90,000 | -49.2% | 620 | -50.0% | 0.02% | -57.1% |
| Q2 2019 | $177,000 | – | 1,240 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |